Predictions
Nanorepro AG
Start price
Target price
Perf. (%)
€9.94
29.11.21
29.11.21
-
29.11.25
29.11.25
-83.35%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.05
03.02.24
03.02.24
-
03.02.25
03.02.25
1.90%
17.02.24
17.02.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.06
26.12.23
26.12.23
-
26.12.24
26.12.24
-8.96%
11.01.24
11.01.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.97
11.11.23
11.11.23
-
11.11.24
11.11.24
-
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.81
05.11.23
05.11.23
-
05.11.24
05.11.24
15.43%
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.01
03.09.23
03.09.23
-
03.09.24
03.09.24
-19.80%
05.11.23
05.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
ifa systems AG
Start price
Target price
Perf. (%)
€3.16
20.08.23
20.08.23
€0.000
20.08.24
20.08.24
-5.70%
03.09.23
03.09.23
Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.28
06.08.23
06.08.23
-
06.08.24
06.08.24
-12.50%
20.08.23
20.08.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
CytoTools AG
Start price
Target price
Perf. (%)
€1.15
28.11.22
28.11.22
-
28.11.23
28.11.23
91.30%
24.04.23
24.04.23
Probably not worthwhile Investment
Nanorepro AG
Start price
Target price
Perf. (%)
€6.38
10.01.22
10.01.22
€7.50
10.01.23
10.01.23
-64.19%
10.01.23
10.01.23
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.84
07.12.21
07.12.21
€5.00
07.12.22
07.12.22
-19.79%
08.12.22
08.12.22
Could be worthwhile Investment >10% per year
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€18.36
27.11.21
27.11.21
€19.00
27.11.22
27.11.22
-50.44%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
CytoTools AG
Start price
Target price
Perf. (%)
€8.50
01.11.21
01.11.21
-
01.11.22
01.11.22
-78.94%
02.11.22
02.11.22
Probably not worthwhile Investment
Nanorepro AG
Start price
Target price
Perf. (%)
€3.97
27.07.22
27.07.22
€15.00
27.08.22
27.08.22
-14.12%
28.08.22
28.08.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Very high dividend yield expected
Top 10 in its market
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.72
07.08.22
07.08.22
-
07.08.23
07.08.23
-13.98%
26.08.22
26.08.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€4.84
10.07.22
10.07.22
€7.00
10.07.23
10.07.23
19.42%
23.07.22
23.07.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.16
09.04.22
09.04.22
-
09.04.23
09.04.23
0.00%
18.04.22
18.04.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€19.50
06.01.22
06.01.22
-
06.01.23
06.01.23
-45.13%
13.03.22
13.03.22
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.98
21.02.21
21.02.21
€10.00
21.02.22
21.02.22
-54.90%
22.02.22
22.02.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.14
09.01.22
09.01.22
-
09.01.23
09.01.23
-5.80%
23.01.22
23.01.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Nanorepro AG
Start price
Target price
Perf. (%)
€3.38
26.11.20
26.11.20
-
16.11.21
16.11.21
198.22%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group